Traumatic Brain Injuries Assessment Market Size - By Product (Screening Devices, Monitoring Devices), By End-use (Hospitals, Diagnostic Centers), & Forecast, 2023 – 2032

Traumatic Brain Injuries Assessment Market Size

Traumatic Brain Injuries Assessment Market size was valued at around USD 3.3 billion in 2022 and it is estimated to reach over USD 7.2 billion in 2032. Increasing prevalence of traumatic brain injuries coupled with rising demand for non-invasive devices for TBI assessment has fueled the market growth.
 

Technological advancements pertaining to traumatic brain injuries assessment has increased the life expectancy among patients with neurological disorders. Additionally, growing awareness regarding clinical benefits offered by these devices for early detection and diagnosis of several neurological ailments has fostered the product demand. Rising healthcare spending for providing better healthcare infrastructure, increasing disposable income and rising government initiatives are some of the major factors responsible for increased adoption of traumatic brain injuries assessment globally.
 

The traumatic brain injuries assessment is a process of assessment and evaluation of to determine the presence, severity, and impact of the TBI on various aspects of the person's physical, cognitive, emotional, and functional well-being. The assessment is intended to provide an accurate diagnosis, identify specific impairments and monitor appropriate treatment and rehabilitation interventions.
 

However, high cost of traumatic brain injuries assessment devices can be a significant barrier and impede the market growth in the coming years. Traumatic brain injuries assessment devices can involve additional costs beyond the standard procedures. Traumatic brain injuries assessment devices are integrated with advance and sophisticated screening and monitoring technologies and can range at a higher price than regular devices. The high costs associated with developing, manufacturing, and acquiring advanced medical devices and technologies may create financial barriers for healthcare institutions, particularly those with limited budgets or resources. Additionally, regions with limited healthcare infrastructure or lower socioeconomic levels may face challenges in accessing and affording these devices. Moreover, the cost of maintaining and upgrading TBI assessment devices, as well as the need for specialized training to operate them, can further add to the overall financial burden.
 

COVID-19 Impact

The recent outbreak of COVID-19 had negatively influenced the traumatic brain injuries assessment market revenue, specifically during the initially phase of 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses domains including the healthcare sector. During the pandemic, individuals with mild to moderate TBIs may have been less likely to seek medical attention or follow up on their injuries due to concerns about exposure to the virus or strained healthcare systems. This reduction in patient visits has led to a decline in the number of TBI assessments conducted globally. Although the market recovered later, thereby mitigating the initial impact. Furthermore, as the number of COVID-19 infected patients decreased significantly and several healthcare facilities began delivering healthcare services, gradually returning the procedural volume to pre-pandemic levels.
 

Traumatic Brain Injuries Assessment Market Trends

Growing incidence of traumatic brain injuries has augmented the market growth. The rise in the number of traumatic brain injuries has resulted in an increased demand for comprehensive assessments, accurate diagnosis, monitoring, and treatment planning. For instance, according to an article published by the Informa UK Limited, in 2021, around 2.5 million people in Europe is estimated to suffer from traumatic brain injury and is expected to increase in the coming years.
 

The growing incidence of TBIs has spurred research and development efforts in the field of assessment technologies. As a result, innovative tools, techniques, and devices have been developed to improve the accuracy, efficiency, and accessibility of TBI assessments. The growing awareness about the impact of TBIs on individuals' health and well-being has led to increased screening initiatives. Technology advancements have facilitated the integration of TBI assessments into digital platforms, enabling remote and convenient evaluation of patients.
 

Traumatic Brain Injuries Assessment Market Analysis

Based on products, the traumatic brain injuries assessment market is categorized into screening devices and monitoring devices. The screening devices segment is further divided into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and others. The monitoring devices is further bifurcated into intracranial pressure (ICP) monitoring and partial pressure of oxygen in brain tissue (pBrO2). The screening devices segment held a dominant market share and is expected to grow at 7.7% CAGR by 2032. This high market share is owing to increasing prevalence of chronic neurological ailments and technological advancements in screening devices has fuelled the market growth. Screening devices allow for the early detection of TBIs, enabling healthcare professionals to identify potential brain injuries and facilitates prompt intervention and treatment.
 

For instance, magnetoencephalography is used in conjunction with MRI for better, improved and precise analysis of neurological ailments. These devices employ standardized protocols and assessment tools, ensuring consistent evaluation with efficiency and reduce subjective biases. Therefore, screening devices in TBI assessment offer valuable clinical benefits by facilitating early detection, providing objective and standardized evaluations, saving time, monitoring progress, and contributing to research efforts thereby propelling the market growth.
 

AlBased on end-use, the traumatic brain injuries assessment market is segmented as hospitals, diagnostic centers, and others. The hospital segment held the highest market share in 2022 and is projected to reach USD 3 billion by 2032. High adoption rate of advanced traumatic brain injuries assessment devices offering enhanced therapeutic outcomes and convenient screening and monitoring procedures would surge the patient preference for hospital setting. Increasing inpatient admissions with neurological disorders and growing disease related awareness initiatives along with the availability of highly skilled healthcare practitioners are some additional aspects that are fueling the expansion of the hospitals segment positively. Thus, availability and accessibility to advanced traumatic brain injuries assessment devices and better treatment & diagnosis coupled with the rising prevalence of chronic ailments will surge patient visits to hospitals, thereby propelling the segment revenue.
 

North America held a leading market share in the global traumatic brain injuries assessment market and is expected to grow at 7.7% CAGR by 2032. The high regional growth is attributed to expanding application of TBI assessment, high disease burden rate, technological advancements, and increased R&D spending, among others. Facilitative government support, favorable business environment, presence of key market players, increase in the number of diagnostic procedures, and rising awareness are other attributes that are anticipated to propel the market growth.
 

Increasing prevalence of neurological ailments such as epilepsy, Parkinson’s disease, multiple sclerosis, stroke, Alzheimer’s disease, etc. are some of the major diseases causing traumatic brain injury. For instance, according to the U.S. Department of Health & Human Services data, in 2021, around 6.5 million Americans are expected to suffer from Alzheimer’s disease. This rising burden of chronic ailments is leading to high incidence of traumatic brain injury among adult population.
 

 Traumatic Brain Injuries Assessment Market Share

Some of the major players operating in the traumatic brain injuries assessment market are:

• Advanced Brain Monitoring Inc
• BioDirection Inc
• BrainScope Inc
• Compumedics Ltd
• InfraScan, Inc
• Integra Lifesciences Corporation
• Koninklijke Philips N.V
• Natus Medical Inc
• Neural Analytics Inc
• Nihon Kohden Corporation and Oculogica
• Raumedic AG

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Traumatic Brain Injuries Assessment Industry News:

• In March 2023, Abbott announced that they had received the U.S. FDA approval for Alinity I, a laboratory instrument to preform traumatic brain injury (TBI) blood test. This instrument will perform rapid i-STAT TBI Plasma test and provide accurate data to quickly assess patients with mild TBI. This regulatory approval helped the company to enhance their R&D capabilities and enhance their market presence.
   
• In January 2019, Oculogica, Inc. announced that they had received the U.S. FDA approval for EyeBOX, a non-invasive, baseline-free test for traumatic brain injury assessment. EyeBOX uses eye-tracking to provide objective information to aid in assessment of patients with suspected concussion. This regulatory approval helped the company to enhance their product portfolio and increase their customer base.
   

Traumatic brain injuries assessment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product, 2018 - 2032 (USD Million)

• Screening Devices    
  • Computerized tomography (CT) scan
  • Magnetic resonance imaging (MRI)
  • Others
• Monitoring Devices   
  • Intracranial Pressure (ICP) Monitoring
  • Partial Pressure of Oxygen in Brain Tissue (pBrO2)

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Diagnostic Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Peru
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel
  • Iran